Answer: Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications that includes semaglutide (Wegovy, Ozempic, Rybelsus), tirzepatide (Zepbound, Mounjaro), liraglutide (Victoza, Saxenda), and orforglipron (Foundayo), have become increasingly popular for obesity treatment (Mehrtash, JAMA Intern Med 2025)
I was a little apprehensive at first making this purchase online but, I couldnt be happier with my entire experience
If you skip a dose of Ozempic, you can develop hyperglycemia, also known as high blood sugar or glucose levels
Are you considering resuming semaglutide treatment but feeling unsure about the next steps
Ozempic, Wegovy, Mounjaro , and Zepbound all play significant roles in the sphere of weight management, though they differ in their mechanisms and areas of impact